Cited 0 time in webofscience Cited 0 time in scopus

Studies on Proteolytic Processing of Amyloid Precursor protein (APP) in Olfactory Epithelium using AD Transgenic Mice

Title
Studies on Proteolytic Processing of Amyloid Precursor protein (APP) in Olfactory Epithelium using AD Transgenic Mice
Authors
Ameer Abu Bakr Rasheed
DGIST Authors
Ameer Abu Bakr Rasheed; Moon, Che Il
Advisor(s)
Moon, Che Il
Co-Advisor(s)
Chang, Keun A
Issue Date
2014
Available Date
2016-05-18
Degree Date
2014. 8
Type
Thesis
Keywords
Alzheimer’s diseaseolfactory systemAmyloid precursor proteinsecretasebi-omarker
Abstract
Olfactory impairment is a well-documented abnormality in Alzheimer’s disease (AD). AD is known to begin with abnormal processing of amyloid precursor protein (APP), through sequen-tial cleavages first by β-secretase and then by γ-secretase complex which leads to excess produc-tion of β-amyloid (Aβ) in the cortex. While olfactory dysfunction occurs in the incipient stages of AD even before Aβ deposition and plaque formation in the CNS, the functional correlation of olfac-tory deficit in relation to AD is not well understood. It may be critical to know the process under-lying AD-related olfactory sensory loss to find some novel biomarkers. To this end, two different types of transgenic mice models were used including Tg2576, which overexpresses human APP and Tg6799 (also called 5xFAD), which expresses human APP and Presenilin1 both mutations to-gether. It was found unique APP processing in OE that has significance in providing not only pos-sible biomarkers that can be used for screening and detection of AD before plaque formation but also for treatment purposes. This data demonstrates that the abnormal processing of APP in the OE provides APP fragments including 25 kDa, 55kDa and 80 kDa that can be a potential biomarker in the very early and critical period in the stage of mild cognitive impairment, that is, the critical stage of AD occurrence (before Aβ plaque formation in the CNS). Such biomarkers can be accessed via biopsy and can be used for establishing improved early diagnostic procedure for the AD. Additionally, PS2 increased level was found in OE that possibly involved in unique APP processing and might also be crucial for under-standing the γ-secretase role controlling AD through γ-secretase as a therapeutic target. ⓒ 2014 DGIST
Table Of Contents
INTRODUCTION 7 -- MATERIAL AND METHODS 11 -- 1.1 Animals 12 -- 1.1.1 Transgenic Alzheimer’s disease model Tg2576 12 -- 1.1.2 Transgenic Alzheimer’s disease model 5XFAD 12 -- 1.2 Olfactory behavior test 13 -- 1.3 RT-PCR 14 -- 1.4 Western blot 15 -- RESULTS 17 -- Chapter 1: Olfactory dysfunction behavior 18 -- Chapter 2: Secretases in olfactory (peripheral) and central nervous system 26 -- Chapter 3: Biomarkers for early Alzheimer’s detection through olfactory system 49 -- DISCUSSION AND CONCLUSION 60 -- REFERENCES 65 -- ABSTRACT IN KOREAN 70 -- ACKNOWLEGMENTS 71 -- CURRICULUM VITAE 73
URI
http://dgist.dcollection.net/jsp/common/DcLoOrgPer.jsp?sItemId=000002262511
http://hdl.handle.net/20.500.11750/981
DOI
10.22677/thesis.2262511
Degree
Master
Department
Brain Science
University
DGIST
Files:
Collection:
Brain and Cognitive SciencesThesesMaster


qrcode mendeley

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE